Letters Screening for MRSA

Use of enteral vancomycin for meticillin resistant Staphylococcus aureus (MRSA) in intensive care

BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2594 (Published 07 April 2014) Cite this as: BMJ 2014;348:g2594
  1. L Silvestri, head of department and unit1,
  2. M A de la Cal, head2,
  3. E Cerda, head3,
  4. M Viviani, consultant4,
  5. H K F van Saene, consultant and reader5
  1. 1Department of Emergency, Unit of Anaesthesia and Intensive Care, Presidio Ospedaliero, Gorizia, Italy
  2. 2Department of Critical Care Medicine, University Hospital, Getafe, Madrid, Spain
  3. 3Intensive Care Unit, Hospital Infanta Cristina, Parla, Spain
  4. 4Department of Anaesthesia and Intensive Care, University Hospital, Trieste, Italy
  5. 5Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool L69 3GA, UK
  1. nia.taylor{at}liv.ac.uk

Coia and colleagues cite two interventions aimed at reducing carriage of meticillin resistant Staphylococcus aureus (MRSA)—intranasal mupirocin and chlorhexidine bathing.1 They did not, however, mention that enteral vancomycin can control MRSA overgrowth, …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe